Precision BioSciences, Inc. (DTIL)
5.82
+0.13
(+2.28%)
USD |
NASDAQ |
Apr 02, 16:00
5.835
+0.02
(+0.26%)
After-Hours: 20:00
Precision BioSciences Research and Development Expense (TTM) : 52.87M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| TG Therapeutics, Inc. | 160.22M |
| Axsome Therapeutics, Inc. | 182.48M |
| MindWalk Holdings Corp. | 3.287M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |